Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities

H-Y Yang1, Y-Y Wen, Y-I Lin

  • 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Oncogene
|June 5, 2007
PubMed

Insights

The protein 14-3-3sigma regulates MDM2, a key factor in cancer. By destabilizing MDM2, 14-3-3sigma stabilizes p53, inhibiting tumor growth and blocking MDM2

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • 14-3-3sigma is a p53-upregulated protein involved in DNA damage response.
  • Its role in tumorigenesis is not fully understood.
  • 14-3-3sigma is an epithelial marker often downregulated in human cancers.

Purpose of the Study:

  • To investigate the precise roles of 14-3-3sigma in tumorigenesis.
  • To elucidate the regulatory relationship between 14-3-3sigma and MDM2.
  • To determine how 14-3-3sigma influences p53 stability and tumor growth.

Main Methods:

  • Protein interaction studies (e.g., RING domain binding).
  • Overexpression and knockout studies to assess MDM2 protein levels and turnover.
  • Live-cell imaging to track protein localization (MDM2, p53).
  • In vivo tumor growth inhibition assays.
  • Analysis of MDM2-mediated post-translational modifications (ubiquitination, NEDDylation).

Main Results:

  • 14-3-3sigma directly interacts with MDM2, particularly at the RING domain.
  • Overexpression of 14-3-3sigma destabilizes MDM2 by enhancing its self-ubiquitination and accelerating turnover.
  • Loss of 14-3-3sigma leads to increased MDM2 protein levels.
  • 14-3-3sigma influences MDM2 localization from the nucleus to the cytoplasm, reversing MDM2-mediated p53 cytoplasmic localization.
  • 14-3-3sigma downregulates MDM2, stabilizing p53 and inhibiting tumor growth in vivo.
  • 14-3-3sigma blocks MDM2-mediated retinoblastoma degradation and p53 NEDDylation.

Conclusions:

  • 14-3-3sigma is a critical regulator of MDM2.
  • 14-3-3sigma inhibits tumorigenesis by destabilizing MDM2, stabilizing p53, and blocking MDM2's oncogenic activities.
  • These findings highlight 14-3-3sigma as a potential therapeutic target in cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...